EUCTR2008-002277-13-DE进行中（未招募）不适用
Double blind, randomized, placebo-controlled clinical trial to proof the efficacy and tolerability of the homeopathic medicinal product Klosterfrau Allergin Globuli in comparison to placebo in children at the age of 6-11 years with hey fever
MCM Klosterfrau Vertriebs GmbH0 个研究点开始时间: 2009年1月30日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •6 - 11 years of age
- •clinically diagnosed hay fever
- •At least 4 of the following symptoms (total sum score of at least 8 points): itchy nose, runny nose, blocked nose, sneezing, red eyes, itchy eyes, tearing
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 260
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Sensitivity to components of the IMP
- •Severe diseases of the respiratory tract (e. g. Asthma bronchiale, chronic bronchial obstruction) as well as other severe organ diseases
- •Intolerability to sacchrose
- •Intake of cromones
- •Intake or topical application of antihistaminics
- •Intake or topical application of glucocorticoids
- •Nasal sympathomimetics
- •Atopic dermatitis (medium to severe grade)
- •Patients with food allergy
- •Person who is committed to a facility (home, psychiatric clinic)
- •Respiratory diseases requiring glucocorticoids
- •Heritable fructose intolerance
- •Specific immune therapy or change of antigen dose within the previous month
研究者
相似试验
已完成
不适用
Improved immune defense by a proprietary larch arabinogalactaImmune functionInfections and InfestationsAcute upper respiratory infectionsISRCTN41183655onza Ltd (Switzerland)200
进行中（未招募）
不适用
A clinical trial to demonstrate the safety and efficacy of a healingwater (Ensinger Schiller Quelle Heilwasser) on constipation compared to placebo- Functional constipation according to the ROME III criteria- The subjects have bowel movements 2 - 4 days/weekMedDRA version: 16.1Level: LLTClassification code 10029932Term: ObstipationSystem Organ Class: 100000004856EUCTR2013-000861-36-DEEnsinger Mineral-Heilquellen GmbH
已完成
不适用
Safety and efficacy of insoluble (1,3)-(1,6)-beta-glucan made from brewers? yeast (Saccharomyces cerevisiae)Immune functionInfections and InfestationsAcute nasopharyngitis [common cold]ISRCTN16094368eiber GmbH (Germany)224
已完成
3 期
Double-blind, placebo-controlled, randomized clinical trial of Fasudil for refractory coronary vasospasm during cardiac catheterization/treatment.refractory coronary vasospasmJPRN-jRCT2091220366Hiroaki Shimokawa26
进行中（未招募）
1 期
Comparison of the efficacy and safety of Sialanar plus oral rehabilitation against placebo plus oral rehabilitation for children and adolescents with drooling and neurodisabiltiesSevere sialorrhoea and neurodisabilties in childrenEUCTR2020-005534-15-FRProveca Pharma LTD80